2.4 semaglutide to tirzepatide vs. Semaglutide: Which Weight Loss Medication is Right for You? tirzepatide with semaglutide vs. Semaglutide:

GLP-3RT Research Applications Researchers across the globe study GLP-3RT for its potential applications in cellular biology, tissue engineering, regenerative medicine, and molecular signaling pathways

Clinical evidence The STEP 1 trial showed participants achieved an average 14.9% weight loss over 68 weeks with semaglutide 2.4 mg

Significant results, ten percent or more of body weight, generally occur between months three and six for patients who stay consistent

The drug acted like a multi-tool for the body: it lowered blood pressure, dropped body weight, and most importantly, reduced inflammation (swelling) inside the arteries